Monomethyl auristatin F (MMAF) is a synthetic antineoplastic agent. It is part of the approved drug belantamab mafodotin in multiple myeloma and some experimental anti-cancer antibody-drug conjugates such as vorsetuzumab mafodotin and SGN-CD19A. In Inter
Clonality:
Monoclonal
Concentration:
2 mg/mL.
Clone Designation:
[A5G12]
Isotype:
IgG1
Buffer:
1*PBS.
Purity:
Protein G affinity purified.
Form:
Liquid
Target:
MMAF antibody Monomethyl auristatin F antibdy
Antibody Type:
Primary Antibody
Application Dilute:
ELISA: 1:5,000-1:20,000
* VAT and and shipping costs not included. Errors and price changes excepted
